Patent details

EP1863492 Title: USE OF MEGESTROL ACETATE FOR IMPROVING HEART FUNCTION AND THE TREATMENT OF HEART INSUFFICIENCY

Basic Information

Publication number:
EP1863492
PCT Application Number:
PCT/EP/2005/012843
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058146283
PCT Publication Number:
WO/2006/058748
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF MEGESTROL ACETATE FOR IMPROVING HEART FUNCTION AND THE TREATMENT OF HEART INSUFFICIENCY
French Title of Invention:
EMPLOI DE L'ACÉTATE DE MÉGESTROL DANS L'AMÉLIORATION DES FONCTIONS CARDIAQUES ET LE TRAITEMENT D'INSUFFISANCES CARDIAQUES
German Title of Invention:
VERWENDUNG VON MEGESTROLACETAT ZUR VERBESSERUNG DER HERZFUNKTION UND BEHANDLUNG VON HERZINSUFFIZIENZ
SPC Number:

Dates

Filing date:
01/12/2005
Grant date:
08/05/2013
EP Publication Date:
08/05/2013
PCT Publication Date:
08/06/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/12/2007
EP B1 Publication Date:
08/05/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/12/2013
Expiration date:
01/12/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/12/2005
 
 

Name:
Par Pharmaceuticals Inc.
Address:
One Ram Ridge Road, Spring Valley, NY 10977, United States (US)

Inventor

Name:
ANKER Stefan
Address:
Germany (DE)

Priority

Priority Number:
04028474
Priority Date:
01/12/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 31/57;
Filing date Document type Number of pages